TAK-664

· Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-664, covering 2025-01-20 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease [Phase 3]